Saraswathi Naravula

Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells.

T. Mcclanahan, A. Willingham, J. Wong, 2017, Cancer research.

IL-10 elicits IFNγ-dependent tumor immune surveillance.

T. Mcclanahan, Xueqing Zhang, Lingling Wu, 2011, Cancer cell.

IL-10 elicits IFNγ-dependent tumor immune surveillance.

T. Mcclanahan, Xueqing Zhang, Lingling Wu, 2011, Cancer cell.

Discovery and Evaluation of TLR-Targeted Immune Agonists.

A. Willingham, W. M. Seganish, Saraswathi Naravula, 2024, Journal of medicinal chemistry.

Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody-Drug Conjugate Payloads.

A. Willingham, W. M. Seganish, Saraswathi Naravula, 2024, Journal of medicinal chemistry.